AI Verdict
MRK has stronger fundamentals based on our AI analysis.
CI vs MRK Fundamental Comparison
| Metric | CI | MRK |
|---|---|---|
| Revenue | $274.9B | $65.0B |
| Net Income | $6.0B | $18.3B |
| Net Margin | 2.2% | 28.1% |
| ROE | 14.3% | 34.7% |
| ROA | 3.8% | 13.3% |
| Current Ratio | 0.85x | 1.54x |
| Debt/Equity | 0.74x | 0.89x |
| EPS | $22.18 | $7.28 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CI vs MRK: Frequently Asked Questions
Is CI or MRK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MRK has stronger fundamentals. CI is rated BUY (76% confidence) while MRK is rated BUY (80% confidence). This is not investment advice.
How does CI compare to MRK fundamentally?
Cigna Group has ROE of 14.3% vs Merck & Co., Inc.'s 34.7%. Net margins are 2.2% vs 28.1% respectively.
Which stock pays higher dividends, CI or MRK?
CI has a dividend yield of N/A or no dividend while MRK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CI or MRK for long term?
For long-term investing, consider that CI has BUY rating with 76% confidence, while MRK has BUY rating with 80% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CI vs MRK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CI vs MRK, the AI consensus favors MRK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.